University of Colorado Receives $1.5 Million for Bone Pathology Research

In 1930 when Doctor Samuel Fosdick Jones retired from his medical practice and teaching at the University of Colorado, the field of bone pathology research was new and emerging. In order to help support this research area, he set up a trust fund that, years after his death, would grant the University of Colorado funding to use in support of this research field. (Image courtesy of Wikimedia Commons).

Now, 68 years after the creation of the fund, the University of Colorado Anschutz Medical Campus has received a gift of $1.5 million from that fund.  

Bone pathology (orthopedic pathology) is the study of disorders with the musculoskeletal system. This system includes joints, bones, muscles, tendons, nerves, and skin, and disorders associated with the system include carpal tunnel syndrome and tendinitis, as well as genetic disorders like scoliosis and limb deformities and treatments.  

Funds from the $1.5 million gift will focus on supporting four main research areas in the Department of Orthopedics: 

1. Research of degenerative joint disease
2. Research of bone-fracture repair and pediatric growth plate tissue engineering
3. Genetics research of scoliosis, limb deformity, and neuromuscular disorders
4. Research of bone cancer and musculoskeletal tumors 

Robert D’Ambrosia, MD, chair of the Department of Orthopedics said that "during the generation when Dr. Jones was here at CU, there were only a couple of people in orthopedics. In the last 13 years, the orthopedics department has gone from being an under-recognized department to being one of the largest [orthopedics] departments in the U.S., with almost 90 full-time faculty. This gift will substantially aid that.” 

(Image courtesy of Biotechnology Calendar, Inc.) 

The University of Colorado Hospital is ranked 45th in the nation by the U.S. News and World Report as one of the top hospitals for Orthopedic research. 

Along with having a top-ranked hospital, the University of Colorado Anschutz Medical Campus is also highly funded in terms of the amount of life science funding it receives annually for research projects. In the 2014 fiscal year, the university received $195 million in funding from the National Institutes of Health. Departments that received substantial amounts of this funding include: 

• Medicine and Internal Medicine - $48.3 million
• Pediatrics - $43.2 million
• Pharmacology - $17.2 million
• Biochemistry - $5.5 million
• Biology - $5.5 million
• Neurology - $5.5 million

*Data from the NIH RePorter

With so much in life science funding to support ongoing research projects, the University of Colorado Anschutz Medical Center is a strong marketplace for lab supply companies to meet with life science researchers looking for new lab products and technologies to use in their labs. Biotechnology Calendar, Inc. holds an annual BioResearch Product Faire™ Event on the University of Colorado Anschutz campus that gives lab suppliers the opportunity to market their products to these Colorado researchers. 

In 2014 more than 400 researchers came to the event to learn about new products available to them, and a similar turn-out is expected at the 6th annual BioResearch Product Faire™ Event on June 18, 2015.

To learn more about participating in the 2015 event, either as en exhibitor or as a researcher, visit the appropriate link below: 

While in Colorado, consider participating in one of the two other Colorado events taking place the same week as the University of Colorado Anschutz Medical Campus event.

Visit the trade show calendar here to find more marketing opportunities in your region.